Evidence map›Paper›PMID 38135776›Full record

ArticleJournal of general internal medicine2024

How to Use Costs in Value-Based Healthcare: Learning from Real-life Examples.

Esmée K J van der Poort, Martha Kidanemariam, Christopher Moriates, Margot M Rakers, Joel Tsevat, Marielle Schroijen, Douwe E Atsma, M Elske van den Akker-van Marle, Willem Jan W Bos, Wilbert B van den Hout

Open access · hybridAbstract read
In one paragraph

Article in Journal of general internal medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Esmée K J van der PoortDepartment of Biomedical Data Sciences, Section of Medical Decision-Making, Leiden University Medical Center, Leiden, The Netherlands. e.k.j.van_der_poort@lumc.nl.ORCID 0000-0001-5364-2558
Martha KidanemariamDepartment of Biomedical Data Sciences, Section of Medical Decision-Making, Leiden University Medical Center, Leiden, The Netherlands.
Christopher MoriatesDepartment of Internal Medicine, Dell Medical School, University of Texas, Austin, TX, USA.
Margot M RakersNational eHealth Living Lab, Leiden University Medical Center, Leiden, The Netherlands.
Joel TsevatDepartment of Medicine and ReACH Center, Joe R. & Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Marielle SchroijenDepartment of Internal Medicine, Section of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
Douwe E AtsmaDepartment of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
M Elske van den Akker-van MarleDepartment of Biomedical Data Sciences, Section of Medical Decision-Making, Leiden University Medical Center, Leiden, The Netherlands.
Willem Jan W BosDepartment of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Wilbert B van den HoutDepartment of Biomedical Data Sciences, Section of Medical Decision-Making, Leiden University Medical Center, Leiden, The Netherlands.
Leiden University Medical Center · NLThe University of Texas at Austin · USThe University of Texas Health Science Center at San Antonio · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare organizations measure costs for business operations but do not routinely incorporate costs in decision-making on the value of care.

aimProvide guidance on how to use costs in value-based healthcare (VBHC) delivery at different levels of the healthcare system. SETTING AND

participantsIntegrated practice units (IPUs) for diabetes mellitus (DM) and for acute myocardial infarction (AMI) at the Leiden University Medical Center and a collaboration of seven breast cancer IPUs of the Santeon group, all in the Netherlands. PROGRAM DESCRIPTION AND EVALUATION: VBHC aims to optimize care delivery to the patient by understanding how costs relate to outcomes. At the level of shared decision-making between patient and clinician, yearly check-up consultations for DM type I were analyzed for patient-relevant costs. In benchmarking among providers, quantities of cost drivers for breast cancer care were assessed in scorecards. In continuous learning, cost-effectiveness analysis was compared with radar chart analysis to assess the value of telemonitoring in outpatient follow-up. DISCUSSION: Costs vary among providers in healthcare, but also between provider and patient. The joint analysis of outcomes and costs using appropriate methods helps identify and optimize the aspects of care that drive desired outcomes and value.

Indexed as

Breast NeoplasmsValue-Based Health CareBenchmarkingDelivery of Health CareFemaleHumansNetherlandsbenchmarkingcontinuous improvementcostsshared decision-makingvalue-based healthcare

Identifiers

PMID38135776
PMCPMC10973291
OpenAlexW4390101781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.